Instructor:
 Katherine Anagnostou, MD, MSc, PhD

Dr. Anagnostou is a distinguished Professor of Pediatrics at Baylor College of Medicine, specializing in pediatric allergy and immunology. Dr. Anagnostou has made significant contributions to the field of food allergy and anaphylaxis. She established pioneering programs such as the Food Allergy Prevention Clinic and the Food Immunotherapy Program, the first of its kind in a US academic center. Her dedication extends beyond clinical care into research and community outreach, where she has led numerous research projects and educational initiatives. Her efforts have earned her multiple honors, including the Woman in Allergy Award by the American College of Allergy, Asthma, and Immunology in 2023. 

Clinical Advisors:

David B.K. Golden, M.D.C.M., F.A.C.P.

Dr. Golden graduated from McGill University School of Medicine in 1976, where he also completed his residency in Internal Medicine. He entered a fellowship training program in Allergy-Clinical Immunology at Johns Hopkins University, where he then directed a program of research studies on anaphylaxis and insect sting allergy for 30 years. In 1984, he founded the allergy practice that grew to Drs. Golden and Matz, LLC. Dr. Golden has published dozens of research papers and is invited to give lectures at national and international scientific meetings. He is now an Associate Professor of Medicine and a teaching clinician at the Johns Hopkins Asthma and Allergy Center. 

In addition to developing educational programs for the American Academy of Allergy Asthma and Immunology, Dr. Golden presents an allergy-immunology curriculum for medical residents in teaching community hospitals in Baltimore. Dr. Golden is the Chief of the Allergy Division of Internal Medicine at Franklin Square Hospital and Sinai Hospital of Baltimore. He continues to be active in the academic allergy community at a national and international level and devotes much of his time to supervising the development of guidelines for allergy practice in the U.S.

Douglas Mack, MSc, MD, FRCPC

Dr. Mack is a Pediatric Allergy, Asthma and Immunology Specialist.   He is an Assistant Clinical Professor in the Department of Pediatrics at McMaster University and is an active member of the Pediatric Emergency Department.  His interests include early childhood allergy prevention, anaphylaxis education and oral food desensitization.

Relevant Financial Relationships

In accordance with the Standards for Integrity and Independence, GW requires all planners, faculty, and others in a position to control the educational content of an accredited CE activity to disclose the absence or existence of all financial relationships (of any dollar amount) with any ineligible companies within the past 24 months.

An ineligible company is any entity whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

GW reviews all disclosure statements to determine which financial relationships are relevant to the educational content of the CE activity. An individual is considered to have a relevant financial relationship if the educational content they can control is related to the business lines or products of the ineligible company.

Relevant Financial Relationships

Dr. Anagnostou is a research grant site principal investigator for Novartis, and medical advisory board member for Ready. Set. Food., Novartis, and Genetech.  

Dr. Golden is a research grant site principal investigator for Regeneron and Eli Lilly, and involved in clinical trials for Genentech, Novartis, GSK, Merck, Astrazeneca, Pfizer, and Teva.  He is a consultant for Novartis, Aquestive, Kokua and Celldex.

Dr. Mack is a speaker for ALK, DBV, Bausch Health, Covis. He is also a research grant site principal investigator for ALK and DBV, and a consultant for ALK, DBV, Alladapt, Bausch Health, Covis.

All relevant financial relationships listed for these individual(s) have been mitigated.

Absence of Relevant Financial Relationships

All others in a position to control the content of this educational activity have no relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

Anti-discrimination Policy

Dr. Anagnostou and the advisors have agreed to our anti-discrimination policy that prohibits the inclusion of discriminatory language, graphics, or references on the basis of race, gender identity, age, color, national origin, physical or mental disability, or religion.